PepGen (PEPG) News Today $2.30 -0.12 (-4.96%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period PepGen Inc. (NASDAQ:PEPG) Short Interest Down 14.1% in DecemberPepGen Inc. (NASDAQ:PEPG - Get Free Report) saw a large drop in short interest in December. As of December 31st, there was short interest totalling 694,200 shares, a drop of 14.1% from the December 15th total of 808,100 shares. Based on an average daily volume of 159,500 shares, the short-interest ratio is currently 4.4 days. Approximately 2.6% of the company's stock are short sold.January 16, 2025 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPGJanuary 8, 2025 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPGJanuary 2, 2025 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. ...December 28, 2024 | gurufocus.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPGDecember 27, 2024 | prnewswire.comWedbush Forecasts PepGen's FY2028 Earnings (NASDAQ:PEPG)PepGen Inc. (NASDAQ:PEPG - Free Report) - Equities research analysts at Wedbush raised their FY2028 earnings per share (EPS) estimates for shares of PepGen in a report released on Monday, December 16th. Wedbush analyst L. Chico now expects that the company will post earnings of ($1.85) per shareDecember 19, 2024 | marketbeat.comFmr LLC Sells 327,160 Shares of PepGen Inc. (NASDAQ:PEPG)Fmr LLC decreased its position in shares of PepGen Inc. (NASDAQ:PEPG - Free Report) by 84.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 61,607 shares of the company's stock after selling 3December 19, 2024 | marketbeat.comNovo builds up manufacturing; Pepgen Duchenne trial put on holdDecember 17, 2024 | yahoo.comBofA downgrades PepGen to Underperform after clinical holdDecember 17, 2024 | markets.businessinsider.comPepGen stock down 22% on FDA clinical hold (update)December 17, 2024 | msn.comPepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular DystrophyDecember 17, 2024 | finance.yahoo.comPepGen (NASDAQ:PEPG) Stock Rating Lowered by Bank of AmericaBank of America downgraded shares of PepGen from a "neutral" rating to an "underperform" rating and set a $3.00 price target for the company. in a report on Monday.December 16, 2024 | marketbeat.comPepGen Shares Tumble Premarket as FDA Puts Study on Clinical HoldDecember 16, 2024 | marketwatch.comPepGen Inc. (NASDAQ:PEPG) Shares Sold by Frazier Life Sciences Management L.P.Frazier Life Sciences Management L.P. lessened its stake in PepGen Inc. (NASDAQ:PEPG - Free Report) by 53.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 702,694 shares of the company's stock after selling 800,094 shares during the quaDecember 10, 2024 | marketbeat.comJanus Henderson Group PLC Increases Stock Position in PepGen Inc. (NASDAQ:PEPG)Janus Henderson Group PLC grew its position in shares of PepGen Inc. (NASDAQ:PEPG - Free Report) by 331.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,336,516 shares of the company's stock after acquirDecember 8, 2024 | marketbeat.comPepGen Inc. (NASDAQ:PEPG) Shares Bought by Suvretta Capital Management LLCSuvretta Capital Management LLC lifted its position in shares of PepGen Inc. (NASDAQ:PEPG - Free Report) by 9.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,660,932 shares of the company's stock after buying an additiNovember 29, 2024 | marketbeat.comTwo new option listings and one option delisting on November 21stNovember 22, 2024 | markets.businessinsider.comPepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical DevelopmentNovember 21, 2024 | businesswire.comPepGen price target lowered to $6 from $10 at BofANovember 18, 2024 | markets.businessinsider.comPepGen (NASDAQ:PEPG) Price Target Cut to $6.00 by Analysts at Bank of AmericaBank of America reduced their target price on PepGen from $10.00 to $6.00 and set a "neutral" rating on the stock in a report on Monday.November 18, 2024 | marketbeat.comFY2024 EPS Estimates for PepGen Boosted by Leerink PartnrsPepGen Inc. (NASDAQ:PEPG - Free Report) - Research analysts at Leerink Partnrs upped their FY2024 earnings per share (EPS) estimates for PepGen in a note issued to investors on Sunday, November 10th. Leerink Partnrs analyst J. Schwartz now expects that the company will earn ($2.91) per share forNovember 13, 2024 | marketbeat.comPepGen Inc. Receives ‘Buy’ Rating Amid Promising Genetic Medicine Advances and Undervalued Stock PositionNovember 13, 2024 | markets.businessinsider.comPepGen Inc. (PEPG) Receives a Buy from Stifel NicolausNovember 11, 2024 | markets.businessinsider.comNewpark Resources Reports Q3 2024 Financial ResultsNovember 9, 2024 | markets.businessinsider.comPepGen (NASDAQ:PEPG) Price Target Cut to $12.00 by Analysts at WedbushWedbush dropped their target price on shares of PepGen from $19.00 to $12.00 and set an "outperform" rating for the company in a report on Friday.November 8, 2024 | marketbeat.comHC Wainwright Reiterates Buy Rating for PepGen (NASDAQ:PEPG)HC Wainwright reissued a "buy" rating and issued a $26.00 price objective on shares of PepGen in a research report on Friday.November 8, 2024 | marketbeat.comPepGen Announces Presentations at the 29th Annual Congress of the World Muscle SocietyOctober 8, 2024 | finance.yahoo.comPepGen (NASDAQ:PEPG) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comCapricor Therapeutics Is Up Over 100%, Could Rise Even Higher (PEPG)Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like iomyopathySeptember 30, 2024 | marketbeat.comPepGen director Christopher Ashton to retire at month's endSeptember 21, 2024 | uk.investing.comPepGen Announces Christopher Ashton, PhD, to Retire from its Board of DirectorsSeptember 19, 2024 | finance.yahoo.comPepGen Announces Christopher Ashton, PhD, to Retire from its Board of DirectorsSeptember 19, 2024 | businesswire.comSofinnova Investments Inc. Raises Stake in PepGen Inc. (NASDAQ:PEPG)Sofinnova Investments Inc. grew its holdings in PepGen Inc. (NASDAQ:PEPG - Free Report) by 11.4% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 561,128 shares of the company's stock after buying an additional 57,504 shares during the period. Sofinnova InSeptember 17, 2024 | marketbeat.comThe Schall Law Firm Is Looking Into PepGen Inc. For Possible Securities Law Infractions And Investors Are Invited To Lend A HandSeptember 11, 2024 | stockhouse.comPepGen (NASDAQ:PEPG) Stock Price Down 0.4%PepGen (NASDAQ:PEPG) Trading Down 0.4%September 5, 2024 | marketbeat.comPepGen Inc Is Being Investigated For Securities Law Infractions And The Schall Law Firm Is Looking For Shareholders To ParticipateAugust 25, 2024 | stockhouse.comPepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & DevelopmentAugust 21, 2024 | finance.yahoo.comPepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & DevelopmentAugust 20, 2024 | finance.yahoo.comIs PepGen Inc. (NASDAQ:PEPG) Trading At A 34% Discount?August 17, 2024 | finance.yahoo.comVanguard Group Inc. Purchases 344,266 Shares of PepGen Inc. (NASDAQ:PEPG)Vanguard Group Inc. raised its position in shares of PepGen Inc. (NASDAQ:PEPG - Free Report) by 68.0% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 850,445 shares of the company's stock after acquiring an additioAugust 14, 2024 | marketbeat.comPepGen Inc. (PEPG)August 13, 2024 | uk.finance.yahoo.comPepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsAugust 13, 2024 | globenewswire.comFY2027 Earnings Estimate for PepGen Inc. (NASDAQ:PEPG) Issued By HC WainwrightPepGen Inc. (NASDAQ:PEPG - Free Report) - Analysts at HC Wainwright reduced their FY2027 earnings estimates for PepGen in a research note issued to investors on Friday, August 9th. HC Wainwright analyst A. Fein now expects that the company will earn $0.04 per share for the year, down from their pAugust 12, 2024 | marketbeat.comPEPG Stock Earnings: PepGen Misses EPS for Q2 2024August 9, 2024 | markets.businessinsider.comPepGen Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsAugust 8, 2024 | finance.yahoo.comPepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsAugust 7, 2024 | globenewswire.comBuy Rating Affirmed for PepGen Inc. as PGN-EDO51 Shows Promise in DMD Treatment LandscapeAugust 1, 2024 | markets.businessinsider.comOptimistic Outlook on PepGen’s DMD Therapy Despite Initial Data: Analyst Reiterates Buy RatingAugust 1, 2024 | markets.businessinsider.comJanus Henderson Group PLC Purchases 178,438 Shares of PepGen Inc. (NASDAQ:PEPG)Janus Henderson Group PLC lifted its position in PepGen Inc. (NASDAQ:PEPG - Free Report) by 18.1% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 1,166,642 shares of the company's stock after purchasing an additional 178,438 shares during the period. JanAugust 1, 2024 | marketbeat.comPepGen (NASDAQ:PEPG) Stock Rating Reaffirmed by HC WainwrightHC Wainwright restated a "buy" rating and set a $26.00 price objective on shares of PepGen in a research report on Thursday.August 1, 2024 | marketbeat.com Get PepGen News Delivered to You Automatically Sign up to receive the latest news and ratings for PEPG and its competitors with MarketBeat's FREE daily newsletter. Email Address PEPG Media Mentions By Week PEPG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PEPG News Sentiment▼0.930.48▲Average Medical News Sentiment PEPG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PEPG Articles This Week▼12▲PEPG Articles Average Week Get PepGen News Delivered to You Automatically Sign up to receive the latest news and ratings for PEPG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Eton Pharmaceuticals News Prime Medicine News Valneva News Korro Bio News enGene News Monte Rosa Therapeutics News Revance Therapeutics News REGENXBIO News Taysha Gene Therapies News Contineum Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PEPG) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PepGen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PepGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PEPG Stock Alerts